System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Benoit Lattuca is an expert in Cardiology at Centre Hospitalier Universitaire de Nîmes (France). As of October 2026, ScienceLeadR ranks Benoit Lattuca in the top 1% of experts worldwide for Myocardial Ischemia. Benoit Lattuca has authored 245 publications, the most recent in 2026, and is an investigator in 27 clinical trials, 6 of them ongoing. SLR score: 1,070 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Benoit Lattuca Centre Hospitalier Universitaire de Nîmes France
1 070 ScienceLeadR Reputation 1070

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Public Health - Biostatistics - Medical Imaging

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2012 - 2026
Source: PubMed

Centre Hospitalier Universitaire de Nîmes

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 245

Citations

Citations: 3 217 1st author: 44 Last author: 20 Unique author: 0

Main journals

Arch Cardiovasc Dis 31
Eur Heart J 20
J Am Coll Cardiol 18
Archives of Cardiovascular Diseases Supplements 15
Archives of cardiovascular diseases. Supplements 15

Best Journals

Eur Heart J 6
N Engl J Med 3
Circulation 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Discontinuation of β-blockers in stable patients with previous myocardial infarction, preserved left ventricular ejection fraction, and no heart failure: a pooled analysis of individual patient data.
PMID 42669300 — myocardial infarction, heart failure, heart, therapeutics		Lancet Top journal20262
Comparison of Local Investigator and Core Laboratory Assessment of Cardiac MRI-derived Left Ventricular Ejection Fraction in the MyocarditIRM Study.
PMID 42560173 — laboratories		Radiol Cardiothorac Imaging20260
Restrictive vs Liberal Transfusion Strategy After Myocardial Infarction: A Post Hoc Analysis of the MINT Randomized Clinical Trial.
PMID 42507445 — hemoglobins, myocardial infarction, anemia, heart failure, probability, heart, clinical medicine		JAMA Netw Open20260
Spontaneous Coronary Reperfusion in STEMI After Pre-Hospital Loading Dose of Triple Antithrombotic Therapy.
PMID 42470298 — incidence, cardiology, st elevation myocardial infarction, reperfusion, myocardial reperfusion, therapeutics		Clin Cardiol20261
Long-Term Follow-up After Percutaneous Coronary Interventions for Chronic Total Occlusions.
PMID 42460748 — percutaneous coronary intervention, cardiology		Clin Cardiol20260

Clinical Studies 27

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 14
Phase 3 9
Phase 4 3
Phase 2/Phase 3 1

By status:

Completed 18
Active not recruiting 4
Recruiting 3
Terminated 1
Unknown 1

By type:

Interventional 20
Observational 7

By Monocentric/Multicentric:

monocentric 11
multicentric2to4 5
multicentric5to9 1
multicentricup10 10

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

6 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
DAPAgliflozine to attenuate cardiac RemOdeling afTEr aCuTe myOcardial infarction
2024-511882-13-01 — myocardial infarction, heart failure, echocardiography, therapeutics		Phase 3Active not recruiting2024
Anticoagulant Regimens Given to achieve thrombus regression and reduce clinical Outcomes among patients with Non device related intra cardiac thrombus a randomized Assessment Under direct oral anticoagulant and vitamin K antagonist Therapy the ARGONAUT trial
2024-512685-33-00 — anticoagulants, vitamins, vitamin k, therapeutics, direct-acting oral anticoagulants		Phase 3Active not recruiting2023
The PERSEVERE Study
NCT06588634 — thromboembolism, embolism, pulmonary embolism, therapeutics, thrombectomy, catheters		N/ARecruiting2024
Anticoagulation Therapy in Non device related Intra cardiac Thrombus
NCT05825573 — anticoagulants, embolism, safety, stroke, myocardial infarction, vitamins, heart failure, heart, rivaroxaban, acute coronary syndrome, acenocoumarol, respect, st elevation myocardial infarction, vitamin k, physicians, patient care, biological monitoring, therapeutics, biological therapy, warfarin, dabigatran, environmental monitoring, direct-acting oral anticoagulants, apixaban, head		Phase 3Active not recruiting2023
Low Risk Non ST Elevation Myocardial Infarction With or Without Intensive Care Unit Admission
NCT05153889 — myocardial infarction, cardiology, st elevation myocardial infarction, intensive care units, non-st elevated myocardial infarction, electrocardiography		N/ARecruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS